Prospector Partners LLC Pfizer Inc Transaction History

Prospector Partners LLC

$863 Million
Q4 2024

A detailed history of Prospector Partners LLC transactions in Pfizer Inc stock. As of the latest transaction made, Prospector Partners LLC holds 88,555 shares of PFE stock, worth $2.33 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

88,555

Previous 81,755 8.32%

Holding current value

$2.33 Million

Previous $2.37 Million 0.68%

% of portfolio

0.27%

Previous 0.26%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$24.8 - $30.19 $168,640 - $205,292	6,800 Added 8.32%	88,555 $2.35 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $8.5 Million - $11 Million	-325,460 Reduced 79.92%	81,755 $2.35 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $3.86 Million - $4.52 Million	120,410 Added 41.98%	407,215 $13.5 Million
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $396,417 - $458,645	10,975 Added 3.98%	286,805 $10.5 Million
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $2.83 Million - $3.68 Million	71,730 Added 35.14%	275,830 $11.3 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $2.46 Million - $3.22 Million	59,025 Added 40.69%	204,100 $10.5 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $36,102 - $44,071	825 Added 0.57%	145,075 $6.35 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $90,733 - $107,581	1,950 Added 1.37%	144,250 $7.56 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $866,962 - $1.07 Million	-18,950 Reduced 11.75%	142,300 $7.37 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $2.26 Million - $3.35 Million	54,650 Added 51.27%	161,250 $9.52 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $4.18 Million - $5.37 Million	106,600 New	106,600 $4.59 Million

Others Institutions Holding PFE

# of Institutions

3,354

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospector Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prospector Partners LLC with notifications on news.

Account

Prospector Partners LLC Pfizer Inc Transaction History